In a model for pancreatic carcinoma and liver metastasis CCR2 deficiency or CCR2 blockade has shown to impair classical monocyte recruitment, angiogenesis inhibition and relief of immunosuppression (139, 143). Here, CCR2 is linked to exocrine pancreatic carcinoma.